Emanuele Papini

Prof. Emanuele Papini

Department of Biomedical Science, Università di Padova, via U Bassi 58/B, I-35131 Padova, Italy
orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 1993 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
ACA Covacci
A Covacci
SCS Censini
S Censini
MBM Bugnoli
M Bugnoli
RPR Petracca
R Petracca
DBD Burroni
D Burroni
NFNatale Figura
Natale Figura
Helicobacter pylori has been associated with gastritis, peptic ulcer, and gastric adenocarcinoma. We report the nucleotide sequence and expression of an immunodominant antigen of H. pylori and the immune response to the antigen during disease. The antigen, named CagA (cytotoxin-associated gene A), is a hydrophilic, surface-exposed protein of 128 kDa produced by most clinical isolates. The size of the cagA gene and its protein varies in different strains by a mechanism that involves duplication of regions within the gene. Clinical isolates that do not produce the antigen do not have the gene and are unable to produce an active vacuolating cytotoxin. An ELISA to detect the immune response against a recombinant fragment of this protein detects 75.3% of patients with gastroduodenal diseases and 100% of patients with duodenal ulcer (P < 0.0005), suggesting that only bacteria harboring this protein are associated with disease.

15 October 1999 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
ISIldiko Szabo
Ildiko Szabo
SBSandra Brutsche
Sandra Brutsche
FTFrancesco Tombola
Francesco Tombola
MMMonica Moschioni
Monica Moschioni
BSBarbara Satin
Barbara Satin
MZMario Zoratti
Mario Zoratti

15 August 1998 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Emanuele PapiniEmanuele Papini
Emanuele Papini
BSB Satin
B Satin
NNN Norais
N Norais
MBMarina De Bernard
Marina De Bernard
JTJ L Telford
J L Telford
CMC Montecucco
C Montecucco
The effects of the vacuolating toxin (VacA) released by pathogenic strains of Helicobacter pylori on several polarized epithelial monolayers were investigated. Trans-epithelial electric resistance (TER) of monolayers formed by canine kidney MDCK I, human gut T84, and murine mammary gland epH4, was lowered by acid-activated VacA. Independent of the cell type and of the starting TER value, VacA reduced it to a minimal value of 1,000-1,300 Omega x cm2. TER decrease was paralleled by a three- to fourfold increase of [14C]-mannitol (molecular weight 182.2) and a twofold increase of [14C]-sucrose (molecular weight 342.3) transmonolayer flux. On the contrary, transmembrane flux of the proinflammatory model tripeptide [14C]-N-formyl-Met-Leu-Phe (molecular weight 437.6), of [3H]-inuline (molecular weight 5,000) and of HRP (molecular weight 47,000) did not change. These data indicate that VacA increases paracellular epithelial permeability to molecules with molecular weight < 350-440. Accordingly, the epithelial permeability of Fe3+ and Ni2+ ions, essential for H. pylori survival in vivo, was also increased by VacA. High-resolution immunofluorescence and SDS-PAGE analysis failed to reveal alterations of junctional proteins ZO-1, occludin, cingulin, and E-cadherin. It is proposed that induction by VacA of a selective permeabilization of the epithelial paracellular route to low molecular weight molecules and ions may serve to supply nutrients, which favor H. pylori growth in vivo.

11 October 1994 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Emanuele PapiniEmanuele Papini
Emanuele Papini
MBMarina De Bernard
Marina De Bernard
EME Milia
E Milia
MBM Bugnoli
M Bugnoli
MZM Zerial
M Zerial
CMC Montecucco
C Montecucco
Pathogenic strains of Helicobacter pylori cause progressive vacuolation and death of epithelial cells. To identify the nature of vacuoles, the distribution of markers of various membrane traffic compartments was studied. Vacuoles derive from the endocytic pathway since they include the fluid-phase marker Lucifer yellow. Early endosome markers such as rab5, transferrin, and transferrin receptor, as well as the lysosomal hydrolase cathepsin D, are excluded from these structures. In contrast, the vacuolar membrane is specifically stained by affinity-purified antibodies against rab7, a small GTPase, localized to late endosomal compartments. The labeling of rab7 on vacuolar membranes increases as vacuolation progresses, without a concomitant increase of cellular rab7. Cell vacuolation is inhibited by the microtubule-depolymerizing agents nocodazole and colchicine. Taken together, these findings indicate that the vacuoles specifically originate from late endosomal compartments.

12 October 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Emanuele PapiniEmanuele Papini
Emanuele Papini
RTRegina Tavano
Regina Tavano
FMFabrizio Mancin
Fabrizio Mancin
Understanding the effects mediated by a set of nanoparticle (NP)-bound host biomolecules, often indicated with the umbrella term of NP corona, is essential in nanomedicine, nanopharmacology, and nanotoxicology. Among the NP-adsorbed proteome, some factors mediate cell binding, endocytosis, and clearing by macrophages and other phagocytes (opsonins), while some others display few affinities for the cell surface (dysopsonins). The functional mapping of opsonins and dysopsonins is instrumental to design long-circulating and nanotoxicologically safe next-generation nanotheranostics. In this review, we critically analyze functional data identifying specific proteins with opsonin or dysopsonin properties. Special attention is dedicated to the following: (1) the simplicity or complexity of the NP proteome and its modulation, (2) the role of specific host proteins in mediating the stealth properties of uncoated or polymer-coated NPs, and (3) the ability of the innate immune system, and, in particular, of the complement proteins, to mediate NP clearance by phagocytes. Emerging species-specific peculiarities, differentiating humans from preclinical animal models (the murine especially), are highlighted throughout this overview. The operative definition of opsonin and dysopsonin and the measurement schemes to assess their in vitro efficacy is critically re-examined. This provides a shared and unbiased approach useful for NP opsonin and dysopsonin systematic identification.

6 June 1994 in FEBS Letters
Verified
Journal Article
Closed access
CMCesare Montecucco
Cesare Montecucco
Emanuele PapiniEmanuele Papini
Emanuele Papini
GSGiampietro Schiavo
Giampietro Schiavo